Champions Oncology, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Champions Oncology, Inc. now
Current reporting with the operating signal separated from the noise.
Champions Oncology, Inc.: Champions Oncology Reports Record Annual Revenue of $59 Million
Investors are testing whether Champions Oncology, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Champions Oncology, Inc.: Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
The story matters when it changes Champions Oncology, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Investors are testing whether Champions Oncology, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Champions Oncology, Inc (CSBR) CEO Ronnie Morris on Q3 2019 Results
The story matters when it changes Champions Oncology, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest CSBR filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Champions Oncology, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →